Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease)
- 1 June 1985
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 142 (6) , 763-764
- https://doi.org/10.1176/ajp.142.6.763
Abstract
Alzheimer''s patients (2) with disabling depression failed to respond to standard antidepressants but improved with a monoamine oxidase inhibitor. The cholinergic system is apparently involved in Alzheimer''s symptoms and demented patients have high monoamine oxidase levels.This publication has 4 references indexed in Scilit:
- The Use of Monoamine Oxidase Inhibitors in the Treatment of Elderly, Depressed PatientsJournal of the American Geriatrics Society, 1984
- The Dexamethasone Suppression Test in Patients with Presenile and Senile Dementia of the Alzheimer's TypeJournal of the American Geriatrics Society, 1984
- Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT)Neurobiology of Aging, 1983
- Neuropharmacology and AgingPublished by Springer Nature ,1978